SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 27, 2011 (May 27, 2011)
HARRIS & HARRIS GROUP, INC.
(Exact name of registrant as specified in its charter)
New York, New York 10018
(Address of principal executive offices and zip code)
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01. Regulation FD Disclosure.
On May 27, 2011, Harris & Harris Group, Inc. (the “Company”) issued a press release disclosing that Solazyme, Inc. has priced its initial public offering (IPO) of 10,975,000 shares of common stock at $18.00 per share. The Company has been an investor in Solazyme, Inc. since 2004. A copy of the Company's press release issued May 27, 2011, is attached as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(a) Not applicable.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.